Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Forbion Capital Partners
Biotech
MapLight raises $373M to plot phase 2 journey for Cobenfy rival
The biotech has started midphase studies in schizophrenia and Alzheimer’s disease psychosis in recent weeks.
Nick Paul Taylor
Jul 28, 2025 10:23am
Versant unveils new autoimmune biotech with $100M fundraise
Apr 24, 2025 8:00am
Forbion's €2B funds are largest yet, with 30 biotechs to benefit
Oct 15, 2024 4:43am
A VC recovery may be coming in Europe: PitchBook
Aug 22, 2024 3:00pm
Why investors are staying loyal to European biotech in 2023
Oct 2, 2023 3:00am
Forbion raises €470M fund, eyes bets enabled by market crash
Jun 9, 2022 2:00am
